Ultrastructure of the hippocampal trisynaptic pathway in schizophrenia

精神分裂症海马三突触通路的超微结构

基本信息

项目摘要

Schizophrenia (SZ) is a devastating mental illness with genetic and environmental risk factors that affects 1% of the world population. Pathology exists in multiple grey and white matter areas and neurotransmitter systems, making the search for a cause(s) and effective treatment elusive. Exploring new pathological mechanisms is paramount in trying to advance our understanding of SZ. The hippocampus is considered to play a pivotal role in the neuropathology and physiology of schizophrenia. Though widely studied, there have been inconsistencies in which subregions, neurotransmitters and cell populations are affected; thus how specific subregion abnormalities contribute to disease expression remain to be fully determined. This proposal aims to identify the circuitry that contribute to region-specific imbalances in excitation and inhibition in the hippocampus in schizophrenia. Here, we propose to test whether there are region-specific differences in the excitatory and inhibitory synapses in the trisynaptic pathway in postmortem tissue of patients with schizophrenia compared to a comparison group using quantitative electron microscopy. My overall hypothesis is two fold: 1) synaptic efficacy of excitatory synapses is enhanced by increased number or size of synapses or increased mitochondrial content in the terminals forming these synapses; and 2) the synaptic efficacy of inhibitory synapses in diminished by decreased number or size of synapses or decreased mitochondrial content in the terminals forming these synapses. Preclinical and clinic data indicate hyperactivity in the hippocampus that precedes the onset of psychosis, and which is correlated with the severity of symptoms. In our preliminary data, we have observed increased numbers of excitatory synapses and decreased number of inhibitory synapses, identified by morphological criteria. SA1) In postmortem brain, we will test the hypothesis that SZ cases have decreased efficacy of inhibitory synapses and an increased efficacy of excitatory synapses in the trisynaptic pathway by counting, measuring and categorizing the morphology of synapses and the mitochondria within the terminals forming them. SA2) To determine the synaptic density on the neuronal somata in the trisynaptic pathway. By examining the exact laminar location of excitatory inputs we will be able to determine the sources of abnormal circuitry. Electron microscopy offers the unique opportunity to measure hippocampal subfields in a layer and cell specific way at the level of the synapse. The source of afferent inputs to specific subfields and layers, the density of specific inputs, and the ultrastructural features of the axon terminals, the experiments in this application have the potential to reveal specific circuitry underlying hyperactivity in the hippocampus in schizophrenia and guide future tests of region and/or cell-specific interventions. Quantitative electron microscopic studies of the human postmortem hippocampus in schizophrenia currently are performed in only one other lab in the world. Our results on the ultrastructural results will have distinct functional implications for schizophrenia as well as for normal human hippocampal circuitry.
精神分裂症(SZ)是一种具有遗传和环境风险因素的破坏性精神疾病

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rosalinda C Roberts其他文献

432 CHONDROCYTE FUNCTION IS DISTURBED IN RATS WITH STUNTED GROWTH FOLLOWING NEONATAL X-IRRADIATION LIMITED TO THE HEAD
  • DOI:
    10.1203/00006450-198104001-00443
  • 发表时间:
    1981-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    H David Mosier;Charles A Sondhaus;Oscar F Zuniga;Regina A Jansons;Cynthia S Biggs;Rosalinda C Roberts
  • 通讯作者:
    Rosalinda C Roberts

Rosalinda C Roberts的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rosalinda C Roberts', 18)}}的其他基金

Ultrastructure of the hippocampal trisynaptic pathway in schizophrenia
精神分裂症海马三突触通路的超微结构
  • 批准号:
    10294349
  • 财政年份:
    2021
  • 资助金额:
    $ 18.56万
  • 项目类别:
White matter pathology in postmortem schizophrenia brain
精神分裂症死后大脑的白质病理学
  • 批准号:
    9016316
  • 财政年份:
    2016
  • 资助金额:
    $ 18.56万
  • 项目类别:
Neuropathology of dopamine systems in schizophrenia
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    6988398
  • 财政年份:
    2005
  • 资助金额:
    $ 18.56万
  • 项目类别:
Neuropathology of dopamine systems in schizophrenia
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    6727543
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Neuropathology of dopamine systems in schizophrenia
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    7012748
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Neuropathology of dopamine systems in schizophrenia
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    6630851
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
NEUROPATHOLOGY OF DOPAMINE SYSTEMS IN SCHIZOPHRENIA
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    8773605
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Neuropathology of dopamine systems in schizophrenia
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    7171934
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
Neuropathology of dopamine systems in schizophrenia
精神分裂症多巴胺系统的神经病理学
  • 批准号:
    6879717
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
PATHOLOGY IN POSTMORTEM SCHIZOPHRENIC BASAL GANGLIA
精神分裂症患者死后基底神经节的病理学
  • 批准号:
    6032200
  • 财政年份:
    1999
  • 资助金额:
    $ 18.56万
  • 项目类别:

相似海外基金

Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
  • 批准号:
    10661090
  • 财政年份:
    2022
  • 资助金额:
    $ 18.56万
  • 项目类别:
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
  • 批准号:
    10501196
  • 财政年份:
    2022
  • 资助金额:
    $ 18.56万
  • 项目类别:
Possible mechanism of action of metabolic syndrome induction in patients treated with atypical antipsychotic agents
使用非典型抗精神病药物治疗的患者诱导代谢综合征的可能作用机制
  • 批准号:
    22590157
  • 财政年份:
    2010
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The use of atypical antipsychotic agents and the risk of breast cancer
非典型抗精神病药物的使用和乳腺癌的风险
  • 批准号:
    192724
  • 财政年份:
    2009
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Operating Grants
Indolobenzox- and Thiazepines as Atypical Antipsychotic Agents
吲哚苯氧和硫氮卓类药物作为非典型抗精神病药
  • 批准号:
    7539253
  • 财政年份:
    2008
  • 资助金额:
    $ 18.56万
  • 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
  • 批准号:
    7676049
  • 财政年份:
    2007
  • 资助金额:
    $ 18.56万
  • 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
  • 批准号:
    7626881
  • 财政年份:
    2007
  • 资助金额:
    $ 18.56万
  • 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
  • 批准号:
    7333930
  • 财政年份:
    2007
  • 资助金额:
    $ 18.56万
  • 项目类别:
Muscarinic receptor activators as antipsychotic agents
作为抗精神病药物的毒蕈碱受体激活剂
  • 批准号:
    7034693
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
Muscarinic receptor activators as antipsychotic agents
作为抗精神病药物的毒蕈碱受体激活剂
  • 批准号:
    8391749
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了